Life Sciences Firm Pivots to Crypto With $425 Million #ETH Strategy


Nasdaq-listed 180 Life Sciences plans to invest $425 million in $ETH and rebrand as ETHZilla Corporation.


The biotechnology firm's stock has plunged over 99.9% since its 2020 IPO, now trading below $3.00.


Electric Capital will manage the company's Ether treasury and oversee yield generation through on-chain activities.


The pivot reflects a broader trend of struggling public companies adopting crypto treasury strategies.


Recent examples include Mill City Ventures raising $441 million for $SUI and Nature's Miracle investing $20 million in $XRP.


According to Charles Schwab, many companies use crypto strategies to boost declining share prices.


Standard Chartered predicts corporations could eventually hold up to 10% of #Ethereum's total supply through #treasury strategies.

image
July 30, 2025 at 12:38 AM
3